Top Markets
#1 Zora Zora +34.71%
#2 0G 0G +21.45%
#3 Full Moon Full Moon +18.73%
#4 AI XOVIA AI XOVIA +17.63%
#5 Notcoin Notcoin +15.96%
#6 Helium Helium +14.00%
#7 Axelar Axelar +13.44%
#8 Wrapped NXM Wrapped NXM +12.47%
#9 rsERG rsERG +12.13%
#10 Yield Basis Yield Basis +11.03%
Coin of the day
Zora Zora
Settings
Language
ENGLISH
Currency
USD
Theme
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Rank in Stocks #12591
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Share Price
$9.09
Last synced: 2023-06-23
Market Cap
$567.77M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade CTI BioPharma Corp. (CTIC)

Category

Healthcare
Earnings for CTI BioPharma Corp. (CTIC)
Earnings in 2026 TTM: 0
According to CTI BioPharma Corp. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for CTI BioPharma Corp. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH